Abstract
Background: Dendrimers are hyperbranched polymeric nanomaterials increasingly used in research, industrial and biomedical applications. Establishing safety profile of these particles includes an understanding of their interactions with blood components and the immune system.
Method: Herein I review the literature demonstrating how tuning dendrimer physicochemical properties influences their interaction with erythrocytes, platelets, plasma proteins, complement and coagulation systems. Dendrimer immunogenicity, adjuvanticity, allergenicity, anti-inflammatory, immunosuppressive and antibacterial properties are also discussed. Conclusion: Dendrimers hemato- and immune- compatibility are determined by particle size, architecture, type and density of surface functional groups. Case studies from the literature are discussed to support this conclusion. The review also highlights questions which require more thorough investigation to fill the gaps in our understanding of immunological properties of dendrimers.Keywords: Dendrimers, nanoparticles, vaccines, adjuvant, antigen, antibody.
Current Pharmaceutical Design
Title:Dendrimers Effects on the Immune System: Insights into Toxicity and Therapeutic Utility
Volume: 23 Issue: 21
Author(s): Marina A. Dobrovolskaia*
Affiliation:
- Leidos Biomedical Research Inc P.O. Box B, 1050 Boyles Street Frederick, MD 21702 – 1201,United States
Keywords: Dendrimers, nanoparticles, vaccines, adjuvant, antigen, antibody.
Abstract: Background: Dendrimers are hyperbranched polymeric nanomaterials increasingly used in research, industrial and biomedical applications. Establishing safety profile of these particles includes an understanding of their interactions with blood components and the immune system.
Method: Herein I review the literature demonstrating how tuning dendrimer physicochemical properties influences their interaction with erythrocytes, platelets, plasma proteins, complement and coagulation systems. Dendrimer immunogenicity, adjuvanticity, allergenicity, anti-inflammatory, immunosuppressive and antibacterial properties are also discussed. Conclusion: Dendrimers hemato- and immune- compatibility are determined by particle size, architecture, type and density of surface functional groups. Case studies from the literature are discussed to support this conclusion. The review also highlights questions which require more thorough investigation to fill the gaps in our understanding of immunological properties of dendrimers.Export Options
About this article
Cite this article as:
Dobrovolskaia A. Marina*, Dendrimers Effects on the Immune System: Insights into Toxicity and Therapeutic Utility, Current Pharmaceutical Design 2017; 23 (21) . https://dx.doi.org/10.2174/1381612823666170309151958
DOI https://dx.doi.org/10.2174/1381612823666170309151958 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Drug-Metabolizing Enzymes Mechanisms and Functions
Current Drug Metabolism Dietary Prevention of Cancer: Anticancer and Antiangiogenic Properties of Green Tea Polyphenols
Medicinal Chemistry Reviews - Online (Discontinued) Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
Current Medicinal Chemistry Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design The Challenge of Exploiting ABCG2 in the Clinic
Current Pharmaceutical Biotechnology Thiopurine Immunomodulators in Ulcerative Colitis: Moving Forward with Current Evidence
Current Drug Targets Immunotherapy of Kidney Cancer
Current Clinical Pharmacology Drug Discovery and the Impact of the Safe Harbor Provision of the Hatch-Waxman Act
Current Topics in Medicinal Chemistry Signal Transduction in Human Cutaneous Melanoma and Target Drugs
Current Cancer Drug Targets RING Finger E3 Ubiquitin Ligases: Structure and Drug Discovery
Current Pharmaceutical Design Recent Trends in the Pharmacological Activity of Isoprenyl Phenolics
Current Medicinal Chemistry Oestrogen-A Protective Factor in Schizophrenia?
Current Psychiatry Reviews Development of Meat and Poultry Products Enriched with n-3 PUFAs and their Functional Role
Current Nutrition & Food Science Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients
Current Drug Targets Targeted Therapy for Brain Tumours: Role of PARP Inhibitors
Current Cancer Drug Targets Anticancer Drugs Discovery and Development from Marine Organisms
Current Topics in Medicinal Chemistry Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease
Current Drug Metabolism Primary Sjogren’s Syndrome and the Type I Interferon System
Current Pharmaceutical Biotechnology GIST and Breast Cancer: 3 Case Reports and a Review of the Literature
Current Cancer Therapy Reviews